share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

福泰製藥 | 4:持股變動聲明-董事 SACHS BRUCE I
美股SEC公告 ·  10/17 16:17

Moomoo AI 已提取核心訊息

Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction on October 15, 2024. The specific details of the transaction, including the number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This financial activity pertains to Vertex Pharmaceuticals, a company known for its focus on developing and commercializing therapies for the treatment of serious diseases.
Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), executed a transaction on October 15, 2024. The specific details of the transaction, including the number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This financial activity pertains to Vertex Pharmaceuticals, a company known for its focus on developing and commercializing therapies for the treatment of serious diseases.
Bruce I. Sachs,與福泰製藥公司(VRTX)有關,於2024年10月15日執行了一項交易。 交易的具體細節,包括股份數量,股份性質,交易價格和發帖交易後的持股情況,在公告中未披露。 這項金融活動涉及福泰製藥,這家以開發和商業化治療嚴重疾病爲重點的公司。
Bruce I. Sachs,與福泰製藥公司(VRTX)有關,於2024年10月15日執行了一項交易。 交易的具體細節,包括股份數量,股份性質,交易價格和發帖交易後的持股情況,在公告中未披露。 這項金融活動涉及福泰製藥,這家以開發和商業化治療嚴重疾病爲重點的公司。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息